Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones.

Press Releases

   View all Press Releases >>
Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results

read more >>
05/08/13
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call

read more >>
05/01/13
Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe

read more >>
04/26/13

Upcoming Events

   View all Events >>
May 18, 2013
American Psychiatric Association
May 18, 2013
Jun 08, 2013
American Psychiatric Association
National Association Director of Nurse Administration
Jul 13, 2013
Alzheimer’s Association International Congress
What's New
Download Documentation 2012 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Avanir Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.